Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 6Sanofi
02 2ANDA Repository
03 2Actavis Inc
04 4Adcock Ingram
05 2Aeron Remedies
06 2Alkem Laboratories
07 4Ascend Labs
08 2Associated Biotech
09 1Athens Life Science
10 8Aurobindo Pharma Limited
11 3BRUNO FARMACEUTICI SpA
12 2Chartwell Pharmaceuticals llc
13 4Clinigen Group
14 5DEVATS INDIA
15 10Daiichi Sankyo
16 2Embiotic Laboratories
17 10Gracure Pharmaceuticals Limited
18 4Health Biotech
19 3Hiral Labs
20 2Jodas Expoim Pvt. Ltd
21 2Kniss Laboratories
22 3Medreich
23 5Nectar Lifesciences
24 3Nishchem International Pvt. Ltd
25 3Nobel Ilac Sanayii Ve Ticaret A.S.
26 2Orchid Pharma
27 4Pfizer Inc
28 4Pharma Dynamics
29 3SCHARPER SpA
30 17Sandoz B2B
31 3Scharper
32 1Shaimil Laboratories
33 1Smith & Kenner Pharmaceuticals
34 3So.Se.Pharm
35 11Sun Pharmaceutical Industries Limited
36 2Theon Pharmaceuticals
37 2Tossvet Pharmaceuticals
38 2Umedica Laboratories
39 4Unosource Pharma
40 7Viatris
41 6World Medicine
42 2XL Laboratories Private Limited
43 1ZOETIS MANUFACTURING ITALIA S.R.L. IT 95121 Catania
44 4Zeiss Pharma
45 6Zim Laboratories
46 3Blank
01 3CAPSULE
02 2Capsule
03 6Cefpodoxime 0.8% 100Ml Oral Use
04 6Cefpodoxime 100Mg 12 Combined Oral Use
05 6Cefpodoxime 200Mg 6 Combined Oral Use
06 2DRY SYRUP
07 5Dispersible Tablet
08 1Dispersible Tablet
09 1Dispersible Tablets
10 1Dry Powder for Oral Suspension
11 2FILM COATED TABLET
12 10FOR SUSPENSION;ORAL
13 7Film Coated Tablet
14 17Film-Coated Tablets
15 2Granulate For Oral Suspension
16 1Granules For Oral Suspension
17 1Granules for Oral Suspension
18 4ORAL SUSPENSION
19 2OS
20 3Oral Suspension
21 1Oral Suspension
22 4POWDER FOR ORAL SUSPENSION
23 3Powder For Oral Suspension
24 2Powder for Oral Suspension
25 1Powder for Suspension
26 16SUS
27 14TAB
28 13TABLET
29 14TABLET;ORAL
30 26Tablet
31 2Taste Masked Granules for Oral Suspension
32 1Uncoated Dispersible Tablet
33 1Uncoated Tablet
34 2 Tablet
01 14DISCN
02 50Generic
03 2Generic EU CTD
04 4Originator
05 1Prescription
06 10RX
07 101Blank
01 4BANAN
02 3CEFODOX
03 1CEFOTOSS 100
04 1CEFOTOSS 200
05 3CEFPODO
06 4CEFPODOXIME MYLAN
07 16CEFPODOXIME PROXETIL
08 3CEFPODOXIME SANDOZ
09 1CEFPORON 100 DT
10 1CEFPORON 200
11 2CEFXL
12 3Cefodox
13 6Cefpodoxa
14 4Cefpodoxim Sandoz
15 1Cefpodoxime 100 Adco
16 1Cefpodoxime 100 mg Alkem
17 1Cefpodoxime 100 mg Ascend
18 1Cefpodoxime 200 Adco
19 1Cefpodoxime 200 mg Alkem
20 1Cefpodoxime 200 mg Ascend
21 2Cefpodoxime 40mg/5ml Adco
22 1Cepodem 100 Tablets
23 1Cepodem 200 Tablets
24 2Cepodem Suspension 40mg/5ml
25 1Dokselin
26 1Dynacef 100 mg
27 1Dynacef 200 mg
28 2Dynacef Suspension
29 1ELPICEF-100 DT
30 1ELPICEF-200 DT
31 2ORCHID CEFPODOXIME 40 mg/ 5 ml
32 3ORELOX
33 2OROPOD 40mg/5ml
34 3OTREON
35 3Orelox
36 1Orelox 100
37 1Orelox 200
38 2Orelox Junior
39 3Otreon
40 3PROXEDOX
41 1Podomil-50
42 1ProxClav 162.5
43 1ProxClav 162.5n
44 2ProxClav 325
45 2ProxClav 81.25
46 3Proxedox
47 1SIMPLICEF
48 1Sandoz Cefpodoxime 100
49 1Sandoz Cefpodoxime 40Mg/5Ml
50 1Sandoz Cefpodoxime 40mg/5ml
51 2Sefpotec
52 1Simayla Cefpodoxime 100
53 2Simayla Cefpodoxime Suspension 40 mg/5 ml
54 1THEOPOXIME-200
55 1THEOPOXIME-50 DS
56 2UMIDOF
57 4VANTIN
58 61Blank
01 1Canada
02 77India
03 37Italy
04 30South Africa
05 4Switzerland
06 9Turkey
07 24USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Orelox
Dosage Form : Cefpodoxime 0.8% 100Ml Oral Use
Dosage Strength : BB os suspe grat 100 ml 40 mg/5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Orelox
Dosage Form : Cefpodoxime 100Mg 12 Combined Oral Use
Dosage Strength : 12 cpr riv 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Orelox
Dosage Form : Cefpodoxime 200Mg 6 Combined Oral Use
Dosage Strength : 6 cpr riv 200 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : ORELOX
Dosage Form : Granulate For Oral Suspension
Dosage Strength : 0.80%
Packaging : 100 ML 0.8% - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : ORELOX
Dosage Form : Film-Coated Tablets
Dosage Strength : 100 mg
Packaging : 12 UNITS 100 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : ORELOX
Dosage Form : Film-Coated Tablets
Dosage Strength : 200 mg
Packaging : 6 UNITS 200 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : RX
Registration Country : USA
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2022-05-18
Application Number : 210568
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2022-05-18
Application Number : 210568
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2007-11-14
Application Number : 65388
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2007-11-14
Application Number : 65388
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2007-06-11
Application Number : 65370
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2007-06-11
Application Number : 65370
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 50MG BASE/5ML
Packaging :
Approval Date : 2007-06-08
Application Number : 65409
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 100MG BASE/5ML
Packaging :
Approval Date : 2007-06-08
Application Number : 65409
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 50MG BASE/5ML
Packaging :
Approval Date : 2009-01-14
Application Number : 90031
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 100MG BASE/5ML
Packaging :
Approval Date : 2009-01-14
Application Number : 90031
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BANAN
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1992-08-07
Application Number : 50687
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BANAN
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 1992-08-07
Application Number : 50687
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BANAN
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 100MG BASE/5ML
Packaging :
Approval Date : 1992-08-07
Application Number : 50688
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BANAN
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 50MG BASE/5ML
Packaging :
Approval Date : 1992-08-07
Application Number : 50688
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VANTIN
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1992-08-07
Application Number : 50674
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VANTIN
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1992-08-07
Application Number : 50674
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VANTIN
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 50MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1992-08-07
Application Number : 50675
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VANTIN
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 100MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1992-08-07
Application Number : 50675
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2008-05-28
Application Number : 65462
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2008-05-28
Application Number : 65462
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 50MG BASE/5ML
Packaging :
Approval Date : 2002-05-31
Application Number : 65082
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 100MG BASE/5ML
Packaging :
Approval Date : 2002-05-31
Application Number : 65082
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2003-08-20
Application Number : 65083
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2003-08-20
Application Number : 65083
Regulatory Info : DISCN
Registration Country : USA
